Karyopharm Therapeutics Inc. buy Royal Bank of Canada
Start price
03.11.23
/
50%
€0.84
Target price
03.11.24
€2.80
Performance (%)
-3.60%
Price
04.10.24
€0.81
Summary
This prediction is currently active. With a performance of -3.60%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 03.11.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Karyopharm Therapeutics Inc. | 24.784% | 24.784% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at Royal Bank of Canada from $4.00 to $3.00. They now have an "outperform" rating on the stock.
Ratings data for KPTI provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.72
07.08.24
07.08.24
€2.75
07.08.25
07.08.25
11.02%
04.10.24
04.10.24
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.67
03.08.23
03.08.23
€3.65
03.08.24
03.08.24
-54.66%
04.08.24
04.08.24